Bristlecone Advisors, LLC Sana Biotechnology, Inc. Transaction History
Bristlecone Advisors, LLC
- $1.18 Billion
- Q2 2025
A detailed history of Bristlecone Advisors, LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 50,000 shares of SANA stock, worth $150,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,000
-0.0%
Holding current value
$150,000
Previous $84,000
61.9%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding SANA
# of Institutions
175Shares Held
115MCall Options Held
337KPut Options Held
337K-
Flagship Pioneering Inc. Cambridge, MA25MShares$75 Million17.82% of portfolio
-
Black Rock Inc. New York, NY11MShares$33.1 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$30.5 Million0.02% of portfolio
-
Baillie Gifford & CO10.1MShares$30.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.87MShares$23.6 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $571M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...